Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nancy Chen, Donghui Cui, Qing Wang, Zhiming Wen, Richard D. Finkelman & Devin Welty. (2018) In vitro drug–drug interactions of budesonide: inhibition and induction of transporters and cytochrome P450 enzymes. Xenobiotica 48:6, pages 637-646.
Read now
Read now
Maisa I. Abdalla & Hans Herfarth. (2016) Budesonide for the treatment of ulcerative colitis. Expert Opinion on Pharmacotherapy 17:11, pages 1549-1559.
Read now
Read now
Marisa Iborra, Diego Álvarez-Sotomayor & Pilar Nos. (2014) Long-term safety and efficacy of budesonide in the treatment of ulcerative colitis. Clinical and Experimental Gastroenterology 7, pages 39-46.
Read now
Read now
Albert J Czaja. (2012) Drug choices in autoimmune hepatitis: Part A – steroids. Expert Review of Gastroenterology & Hepatology 6:5, pages 603-615.
Read now
Read now
Articles from other publishers (30)
Bogdan Obrișcă, Alexandra Vornicu, Valentin Mocanu, George Dimofte, Andreea Andronesi, Raluca Bobeică, Roxana Jurubiță, Bogdan Sorohan, Nicu Caceaune & Gener Ismail. (2023) An open-label study evaluating the safety and efficacy of budesonide in patients with IgA nephropathy at high risk of progression. Scientific Reports 13:1.
Crossref
Crossref
Saad Elzayat, Hesham Lasheen, Ibrahim Gehad, Mohamed E. El‐Deeb, Islam Soltan, Mohammad M. Aouf & Ahmed Elgendy. (2023)
The Efficacy of Budesonide as Intrapolyp Injection Agent in the Management of Type 2
CRSwNP
. The Laryngoscope.
Crossref
Crossref
Fatemeh Soltani, Hossein Kamali, Abbas Akhgari, Mahboobeh Ghasemzadeh Rahbardar, Hadi Afrasiabi Garekani, Ali Nokhodchi & Fatemeh Sadeghi. (2023) Combination of time-dependent polymer and inulin as a coating for sustained delivery of budesonide pellets aimed for use in IBD treatment. Journal of Drug Delivery Science and Technology 88, pages 104927.
Crossref
Crossref
Vita D'Amico, Ilaria Arduino, Mirco Vacca, Rosa Maria Iacobazzi, Davide Altamura, Antonio Lopalco, Rosanna Rizzi, Annalisa Cutrignelli, Valentino Laquintana, Franco Massimo, Maria De Angelis, Nunzio Denora & Angela Assunta Lopedota. (2023) Colonic budesonide delivery by multistimuli alginate/Eudragit® FS 30D/inulin-based microspheres as a paediatric formulation. Carbohydrate Polymers 302, pages 120422.
Crossref
Crossref
Jian Liao, Yijing Zhou, Xiuqin Xu, Ke Huang, Pengtao Chen, Yuhao Wu, Biao Jin, Qianlong Hu, Guanlin Chen & Shankun Zhao. (2023) Current knowledge of targeted-release budesonide in immunoglobulin A nephropathy: A comprehensive review. Frontiers in Immunology 13.
Crossref
Crossref
Rakesh Kumar Mishra, Anas Ahmad, Kanika, Ajay Kumar, Akshay Vyawahare, Rahul Sakla, Ahmed Nadeem, Nahid Siddiqui, Syed Shadab Raza & Rehan Khan. (2022) Caffeic Acid-Conjugated Budesonide-Loaded Nanomicelle Attenuates Inflammation in Experimental Colitis. Molecular Pharmaceutics 20:1, pages 172-182.
Crossref
Crossref
Rajasree Chakraborty & Srinivas Patnaik. 2023. Epigenetics in Organ Specific Disorders. Epigenetics in Organ Specific Disorders
585
613
.
Farah Yasmin, Hala Najeeb, Unaiza Naeem, Abdul Moeed, Thoyaja Koritala & Salim Surani. (2022) Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease. World Journal of Clinical Cases 10:21, pages 7195-7208.
Crossref
Crossref
Ron Feiner, Eleanor Johns, Merav Antman-Passig, Takeshi Irie, Naxhije Berisha, Hadas Oved, Doha Khan, Lukasz Witek, Richard M. White & Daniel A. Heller. (2022) Drug-Eluting Rubber Bands for Tissue Ligation. ACS Applied Materials & Interfaces 14:24, pages 27675-27685.
Crossref
Crossref
Sai Pavan Kumar BandaruMathrusri Annapurna Mukthinuthalapati. (2022) Development and validation of a new stability indicating RP-HPLC method for the quantification of Budesonide in pharmaceutical dosage forms in presence of an internal standard. Research Journal of Pharmacy and Technology, pages 2103-2109.
Crossref
Crossref
Ye Liu, Lingling Xu, Qiuyun Zhang, Yong Kang, Lifeng Liu, Zheng Liu, Yuxing Wang, Xuejiao Jiang, Yizhu Shan, Ruizeng Luo, Xi Cui, Yuan Yang, Xinchun Yang, Xiaoqing Liu & Zhou Li. (2022) Localized Myocardial Anti-Inflammatory Effects of Temperature-Sensitive Budesonide Nanoparticles during Radiofrequency Catheter Ablation. Research 2022.
Crossref
Crossref
Yu Hu, Zhen Ye, Mingquan Wu, Yingqi She, Linzhen Li, Yujie Xu, Kaihua Qin, Zhipeng Hu, Maoyi Yang, Fating Lu & Qiaobo Ye. (2021) The Communication Between Intestinal Microbiota and Ulcerative Colitis: An Exploration of Pathogenesis, Animal Models, and Potential Therapeutic Strategies. Frontiers in Medicine 8.
Crossref
Crossref
. (2021) Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing). Journal of Digestive Diseases 22:6, pages 298-317.
Crossref
Crossref
Klaus Fellermann, Ingolf Schiefke, István Rácz, Jelena Derova, Laimas Jonaitis, Sarah Wehrum, Tanju Nacak & Roland Greinwald. (2020) Efficacy and safety of prolonged release budesonide granules in mesalazine‐refractory ulcerative colitis: A multi‐centre Phase IIa study (TOPICAL‐1). United European Gastroenterology Journal 8:10, pages 1186-1195.
Crossref
Crossref
Rosanna Coppo & Christophe Mariat. (2020) Systemic corticosteroids and mucosal-associated lymphoid tissue-targeted therapy in immunoglobulin A nephropathy: insight from the NEFIGAN study. Nephrology Dialysis Transplantation 35:8, pages 1291-1294.
Crossref
Crossref
Gener Ismail, Bogdan Obrişcă, Roxana Jurubiţă, Andreea Andronesi, Bogdan Sorohan, Alexandra Vornicu, Ioanel SinescuMihai Hârza. (2020) Budesonide versus systemic corticosteroids in IgA Nephropathy. Medicine 99:26, pages e21000.
Crossref
Crossref
Antonio Tursi, Angela Marinelli, Francesca Laera & Antonio Penna. (2019) Complicated diverticulitis mimicking colonic carcinoma: combined approach with endoscopy and budesonide. BMJ Case Reports 12:12, pages e230608.
Crossref
Crossref
João C. Campos, Domingos C. Ferreira, Sofia Lima, Salette Reis & Paulo J. Costa. (2019) Swellable polymeric particles for the local delivery of budesonide in oral mucositis. International Journal of Pharmaceutics 566, pages 126-140.
Crossref
Crossref
Sophie E. Berends, Anne S. Strik, Mark Löwenberg, Geert R. D’Haens & Ron A. A. Mathôt. (2018) Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis. Clinical Pharmacokinetics 58:1, pages 15-37.
Crossref
Crossref
Stephan Miehlke, Daniela Aust, Emese Mihaly, Peter Armerding, Günther Böhm, Ole Bonderup, Fernando Fernández-Bañares, Juozas Kupcinskas, Lars Kristian Munck, Kai-Uwe Rehbehn, Tanju Nacak, Roland Greinwald, Andreas Münch, Jiri Stehlk, Ole Bonderup, Lars Kristian Munck, Terje Rannem, Peter Armerding, Michael Bläker, Günter Böhm, Mark Hoesl, Christian Kirsch, Ahmed Madisch, Eberhard Meier, Stephan Miehlke, Kai-Uwe Rehbehn, Gyula G. Kiss, Ferenc Nagy, Zsolt Tulassay, Ferenc Zsigmond, Limas Kupcinskas, Gerd Bouma, Marieke Pierik, Fernando Fernández-Bañares, Alfredo J. Lucendo, Johan Bohr, Per Hellström, Barbro Lebrun, Greger Lindberg, Andreas Münch, Lina Vigren, Miroslav Wielondek, Martin Krauss, Axel Dignass & Wolfgang Kruis. (2018) Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis. Gastroenterology 155:6, pages 1795-1804.e3.
Crossref
Crossref
Amy Hemperly, William J Sandborn & Niels Vande Casteele. (2018) Clinical Pharmacology in Adult and Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases 24:12, pages 2527-2542.
Crossref
Crossref
Seong-Ryeol Kim, Jae-Hyoung Song, Jae-Hee Ahn, Geun-Shik Lee, Huijeong Ahn, Sung-il Yoon, Seung Goo Kang, Pyeung-Hyeun Kim, Sang-Min Jeon, Eun-Ji Choi, Sooyoung Shin, Younggil Cha, Sungchan Cho, Dong-eun Kim, Sun-Young Chang & Hyun-Jeong Ko. (2018) Antiviral and anti-inflammatory activity of budesonide against human rhinovirus infection mediated via autophagy activation. Antiviral Research 151, pages 87-96.
Crossref
Crossref
Silvia Nardelli, Laura Francesca Pisani, Gian Eugenio Tontini, Maurizio Vecchi & Luca Pastorelli. (2017)
MMX
®
technology and its applications in gastrointestinal diseases
. Therapeutic Advances in Gastroenterology 10:7, pages 545-552.
Crossref
Crossref
Yassmin O. Samak, Magda El Massik & Allan G.A. Coombes. (2017) A Comparison of Aerosolization and Homogenization Techniques for Production of Alginate Microparticles for Delivery of Corticosteroids to the Colon. Journal of Pharmaceutical Sciences 106:1, pages 208-216.
Crossref
Crossref
Marcin Włodarczyk & Aleksandra Sobolewska-Włodarczyk. 2017. Introduction to Gastrointestinal Diseases Vol. 1. Introduction to Gastrointestinal Diseases Vol. 1
113
124
.
Gerda C Leitner. (2016) Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World Journal of Gastrointestinal Pharmacology and Therapeutics 7:1, pages 5.
Crossref
Crossref
Mary E Sherlock, John K MacDonald, Anne Marie Griffiths, A Hillary Steinhart & Cynthia H Seow. (2015) Oral budesonide for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2015:10.
Crossref
Crossref
Pete Otovic, Shanequa Smith & Eric Hutchinson. (2015) The use of glucocorticoids in marmoset wasting syndrome. Journal of Medical Primatology 44:2, pages 53-59.
Crossref
Crossref
Karin Nilsson, Maria Andersson & Olof Beck. (2014) Phospholipid removal combined with a semi-automated 96-well SPE application for determination of budesonide in human plasma with LC–MS/MS. Journal of Chromatography B 970, pages 31-35.
Crossref
Crossref
Stephan Miehlke, Ahmed Madisch, Limas Kupcinskas, Dalius Petrauskas, Günter Böhm, Hans-Joachim Marks, Michael Neumeyer, Torben Nathan, Fernando Fernández-Bañares, Roland Greinwald, Ralf Mohrbacher, Michael Vieth & Ole K. Bonderup. (2014) Budesonide Is More Effective Than Mesalamine or Placebo in Short-term Treatment of Collagenous Colitis. Gastroenterology 146:5, pages 1222-1230.e2.
Crossref
Crossref